LinkedIn Profile

Access Redbiotec historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:redbiotec 1783077 May 31st, 2019 12:00AM Redbiotec AG 493 14.00 Open Biotechnology May 31st, 2019 10:05AM May 31st, 2019 10:05AM Redbiotec is a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Founded in 2006 as a spin-off of the Swiss Federal Institute of Technology in Zurich (ETH Zurich), the company has won several awards, including the renowned W.A. De Vigier Award. Backed by internationally recognized scientists as Scientific Advisors, the company has a dedicated scientific team with expertise in multiple disciplines from immunology and microbial engineering to protein engineering. Presently, Redbiotec is developing immunotherapies for cancer and herpes: 1. HSV-2 immunotherapy program, which builds upon our prior success in vaccine development that led to Pfizer’s acquisition of our CMV vaccine program. 2. Living medicines programs based on proprietary engineered bacteria: a) Immuno-oncology therapy combining oncolytic virus with engineered bacteria to turn “cold” tumours hot. Our lead candidate is RON1, for treating pancreatic cancer b) Gene therapy delivery using engineered bacteria. Our lead candidate is RONC3, for treating HPV-mediated cervical cancer We actively evaluate partnering opportunities with the ultimate goal of reinforcing our portfolio, and/or to add value to the therapies developed by our collaboration partners, in order to meet unmet patient needs. We welcome strategic partnerships to further the development of our preclinical assets and to increase the impact of our technology platforms. Open Vaccines, Virus-like particles (VLPs), Biologics, Proteins, Protein complexes, Oncolytic bacteria, Herpes, HSV-2, Gene therapy delivery, Immunotherapy, Oncolytic virus, Immuno-oncology, Pancreatic cancer, Cervical cancer, HPV, Protein engineering, Microbial engineering, Therapeutic vaccine Open Wagistrasse 23 Zurich Zurich CH 8952 Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Mar 18th, 2018 12:00AM Redbiotec AG 382 9.00 Open Biotechnology Mar 18th, 2018 02:31PM Mar 18th, 2018 02:31PM Open Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 17th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 16th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 15th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 14th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 13th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 12th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 11th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services
private:redbiotec 1783077 Feb 10th, 2018 12:00AM Redbiotec AG 342 13.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Redbiotec, a Swiss biotechnology company, develops immunotherapies against Herpes and cancer. Our therapies are based on best-in-class proteins and microorganisms. Redbiotec has a therapeutic vaccine program against HSV-2 and an oncology program. Track record of Redbiotec in novel proteins: • Deals closed with pharma companies in U.S., Asia and Europe • Trade sale of spin-off Redvax to Pfizer for its CMV vaccine program • Internationally recognized scientists as scientific advisors • Engineering and production of >100 novel proteins and protein complexes • First company having successfully developed stable CMV pentamer at >95% purity Redbiotec is backed by experienced institutional and private investors. Redbiotec Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.